Not A Member?       Forget Password?
          Click HERE                   Click HERE
   and Register FREE
   LATEST INTERVIEWS
-
Fibrocell Science, Inc.
( :FCSC ) / David Pernock
 
-
diaDexus, Inc.
( OTCBB:DDXS ) / Dr. Brian Ward
 
-
NovaBay Pharmaceuticals, Inc.
( NYSE:NBY ) / Ron Najafi, Ph.D. Thomas Paulson, M.B.A.
 
-
EnerJex Resources, Inc.
( OTCBB:ENRJ ) / Robert Watson, Jr. Atticus Lowe
 
-
League Now Holdings Corporation (Infiniti Systems Group, Inc.)
( OTCBB:LNWZ ) / Mr. John L. Bianco Mr. D. Bruce Veness
 
-
Sunshine Biopharma, inc.
( OTCBB:SBFM ) / Steve N. Slilaty Camille Sebaaly
 
-
TheraBiogen, Inc.
( OTCBB:TRAB ) / Kelly Hickel
 
-
Trimedyne, Inc.
( OTCBB:TMED ) / Marvin P. Loeb
 
-
XsunX Inc.
( OTCBB:XSNX ) / Mr. Tom M. Djokovich
 
 
   CEOcast WEEKLY NEWSLETTER  
  
April 14, 2014 CEOcast Weekly Newsletter
Companies featured in the current edition of the newsletter: KIN, RTGN Stocks continued to tumble last week in what may have been an overdue market correction, bringing down inflated tech sector and m... Click here for more...
 
   
   STOCKS ON THE MOVE  

Advanced Cell Technology, Inc.
 

 

Advanced Cell Technology, Inc., is a biotechnology company that specializes in the development of cellular therapies for the treatment of diseases and conditions that impact tens of millions of people worldwide. The company applies stem cell-based technologies (both adult and human embryonic) and other proprietary methods in the field of regenerative medicine to bring patient-specific therapies from the lab bench to the bedside.

ACT’s principal laboratory and GMP facility is in Marlborough, Massachusetts, and its corporate offices are in Santa Monica, California. ACT is led by an experienced management team and a world-class scientific team helmed, respectively, by Chairman and Chief Executive Officer Gary Rabin and Chief Scientific Officer Robert Lanza, M.D.


 
Oculus Innovative Sciences, Inc.
 

Oculus Innovative Sciences is a commercial healthcare company that develops and brings to market innovative solutions to medical problems that have the potential to improve the quality of life and care of patients worldwide. With the growth in access to medical services around the world, combined with a growing population of elderly and disabled people,  the rapidly expanding healthcare market is in need of new, more cost effective solutions to medical problems. Headquartered in Petaluma, California, Oculus is currently working on the clinical development of different applications of Microcyn® Technology, a patented solution/gel designed to prevent the growth of microorganisms with a wide variety of medical applications. The company has already begun distribution of various Microcyn® products in several markets, and continues to develop new treatments for a number of medical conditions and purposes, making it an exciting opportunity for investors interested in a company with existing products that also show great promise for futher medical applications.

 

 
     
 
 
Copyright © 2001-2014. All Rights Reserved. Disclaimer | Privacy Policy